The distribution of tau pathology in both AD and FTD-tau tends to correlate with cognitive decline, brain areas of atrophy, and the disease stage, and therefore tau misfolding and aggregation is considered to be a link to common downstream mechanisms of neurodegeneration [3,6,16,28,36,37]. The gene discussed is MAPT; the disease is Alzheimer disease.